Insights

Health and Life Sciences icon

How exposed is the global health system to geopolitical tensions?

Health and Life Sciences

Mark Loughridge
|

The COVID-19 pandemic has shone a light on the fragility of the public health systems that we take for granted. As the virulence of the pandemic begins to abate across much of the world, how exposed – or prepared – are counties for the impact of war, economic sanctions, political isolation and new migratory patterns on existing health structures and systems? 

Read more
Health and Life Sciences icon

Does the UK government ‘get’ science?

Health and Life Sciences

Mark Loughridge
|

Mark Loughridge, Dr Rupert Lewis, Andrew Croydon and Miranda Lutz discuss the ‘science gap’ between government and scientists.

Read more
Health and Life Sciences icon

Will capacity constraints scupper the UK Government’s vision for post Brexit medical devices regulation?

Health and Life Sciences

Mark Loughridge
|

In September, the UK Medicines and Healthcare products Regulatory Agency (MHRA) issued its long-anticipated consultation on the UK’s post Brexit medical devices regime. For all the early talk of substantial divergence from existing EU rules, the UK Government is in fact proposing greater regulatory alignment and a focus on pathways so far not offered by other major…

Read more